Clinical trial
Radiation Therapy in Treating Patients With Glioblastoma
NCT00019058 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019058 |
|---|---|
| Title | Radiation Therapy in Treating Patients With Glioblastoma |
| Official title | A PHASE I STUDY OF COMBINED RADIATION RESPONSE MODIFIERS EMPLOYING HYDROXYUREA AND PENTOXIFYLLINE FOR TREATMENT OF GLIOBLASTOMA |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Radiation |
| Interventions | chemotherapy, hydroxyurea, pentoxifylline, radiation therapy |
| Enrollment | 34 |
| Start date | Apr 1, 1995 |
| First posted | Apr 5, 2004 |
| Last update posted | Apr 29, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: